October 10, 2024 Professional Services Program – Reimbursement Methodology LAC 50:IX.15113
Back to Main Notices of Intent Page
Amends the provisions governing reimbursement methodology in the Professional Services Program in order to allow coverage of physician-administered biosimilar drugs in Mary Bird Perkins Cancer Centers and establish the reimbursement methodology for their use.
Contact Information: Kimberly Sullivan, JD, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030
Disclaimer: Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm. The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.
RELATED ITEMS
Emergency Rule: N/A
Notice of Intent
Prior to Proposed Rule: August 2024 LAC